HEADER HYDROLASE/INHIBITOR 06-OCT-12 4BDT TITLE HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH HUPRINE W AND FASCICULIN 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACHE; COMPND 5 EC: 3.1.1.7; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: FASCICULIN-2; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: FAS-2, FAS2, ACETYLCHOLINESTERASE TOXIN F-VII, FASCICULIN- COMPND 11 II, FAS-II, TOXIN TA1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO-K1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGS; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: DENDROASPIS ANGUSTICEPS; SOURCE 13 ORGANISM_COMMON: EASTERN GREEN MAMBA; SOURCE 14 ORGANISM_TAXID: 8618 KEYWDS HYDROLASE-INHIBITOR COMPLEX, BUTYRYLCHOLINESTERASE, NERVE KEYWDS 2 TRANSMISSION, INHIBITION, ALPHA-BETA HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR F.NACHON,E.CARLETTI,C.RONCO,M.TROVASLET,Y.NICOLET,L.JEAN,P.-Y.RENARD REVDAT 5 20-DEC-23 4BDT 1 REMARK HETSYN REVDAT 4 29-JUL-20 4BDT 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 28-FEB-18 4BDT 1 SOURCE JRNL REMARK REVDAT 2 31-JUL-13 4BDT 1 JRNL REVDAT 1 29-MAY-13 4BDT 0 JRNL AUTH F.NACHON,E.CARLETTI,C.RONCO,M.TROVASLET,Y.NICOLET,L.JEAN, JRNL AUTH 2 P.Y.RENARD JRNL TITL CRYSTAL STRUCTURES OF HUMAN CHOLINESTERASES IN COMPLEX WITH JRNL TITL 2 HUPRINE W AND TACRINE: ELEMENTS OF SPECIFICITY FOR JRNL TITL 3 ANTI-ALZHEIMER'S DRUGS TARGETING ACETYL- AND JRNL TITL 4 BUTYRYL-CHOLINESTERASE. JRNL REF BIOCHEM. J. V. 453 393 2013 JRNL REFN ESSN 1470-8728 JRNL PMID 23679855 JRNL DOI 10.1042/BJ20130013 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 19627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 982 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 57.9440 - 5.9360 0.97 2731 144 0.1568 0.1920 REMARK 3 2 5.9360 - 4.7123 0.99 2694 141 0.1392 0.1658 REMARK 3 3 4.7123 - 4.1168 0.99 2663 140 0.1183 0.1932 REMARK 3 4 4.1168 - 3.7405 0.99 2667 141 0.1385 0.2102 REMARK 3 5 3.7405 - 3.4724 0.99 2666 140 0.1801 0.2558 REMARK 3 6 3.4724 - 3.2677 0.99 2625 139 0.2256 0.3233 REMARK 3 7 3.2677 - 3.1041 0.97 2599 137 0.2627 0.3820 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.360 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 5088 REMARK 3 ANGLE : 1.291 6945 REMARK 3 CHIRALITY : 0.082 738 REMARK 3 PLANARITY : 0.007 910 REMARK 3 DIHEDRAL : 18.319 1845 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 0.4631 -40.5065 -58.4343 REMARK 3 T TENSOR REMARK 3 T11: 0.2887 T22: 0.0894 REMARK 3 T33: 0.2081 T12: 0.0340 REMARK 3 T13: 0.0166 T23: 0.0542 REMARK 3 L TENSOR REMARK 3 L11: 1.4688 L22: 1.0520 REMARK 3 L33: 1.6733 L12: -0.1864 REMARK 3 L13: 0.0954 L23: 0.0814 REMARK 3 S TENSOR REMARK 3 S11: 0.0257 S12: -0.0342 S13: 0.0748 REMARK 3 S21: 0.0915 S22: -0.0296 S23: -0.0205 REMARK 3 S31: -0.1714 S32: -0.0290 S33: 0.0316 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): -19.4319 -36.7207 -38.2366 REMARK 3 T TENSOR REMARK 3 T11: 0.7041 T22: 0.3712 REMARK 3 T33: 0.4119 T12: 0.1027 REMARK 3 T13: 0.0665 T23: 0.0080 REMARK 3 L TENSOR REMARK 3 L11: 1.1186 L22: 0.0157 REMARK 3 L33: 0.5367 L12: 0.0830 REMARK 3 L13: 0.7536 L23: 0.0423 REMARK 3 S TENSOR REMARK 3 S11: 0.0930 S12: -0.6102 S13: 0.2410 REMARK 3 S21: 0.4340 S22: -0.0970 S23: 0.3343 REMARK 3 S31: -0.9828 S32: -0.3926 S33: 0.0022 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4BDT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1290054355. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9790 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19677 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 58.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.66000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2X8B REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 75.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES BUFFER PH 7.4, 1.3 M REMARK 280 AMMONIUM SULFATE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 7555 X+2/3,Y+1/3,Z+1/3 REMARK 290 8555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 9555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 10555 Y+2/3,X+1/3,-Z+1/3 REMARK 290 11555 X-Y+2/3,-Y+1/3,-Z+1/3 REMARK 290 12555 -X+2/3,-X+Y+1/3,-Z+1/3 REMARK 290 13555 X+1/3,Y+2/3,Z+2/3 REMARK 290 14555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 15555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 16555 Y+1/3,X+2/3,-Z+2/3 REMARK 290 17555 X-Y+1/3,-Y+2/3,-Z+2/3 REMARK 290 18555 -X+1/3,-X+Y+2/3,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 75.80000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 43.76315 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 82.13333 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 75.80000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 43.76315 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 82.13333 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 75.80000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 43.76315 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 82.13333 REMARK 290 SMTRY1 10 -0.500000 0.866025 0.000000 75.80000 REMARK 290 SMTRY2 10 0.866025 0.500000 0.000000 43.76315 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 82.13333 REMARK 290 SMTRY1 11 1.000000 0.000000 0.000000 75.80000 REMARK 290 SMTRY2 11 0.000000 -1.000000 0.000000 43.76315 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 82.13333 REMARK 290 SMTRY1 12 -0.500000 -0.866025 0.000000 75.80000 REMARK 290 SMTRY2 12 -0.866025 0.500000 0.000000 43.76315 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 82.13333 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 87.52630 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 164.26667 REMARK 290 SMTRY1 14 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 14 0.866025 -0.500000 0.000000 87.52630 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 164.26667 REMARK 290 SMTRY1 15 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 15 -0.866025 -0.500000 0.000000 87.52630 REMARK 290 SMTRY3 15 0.000000 0.000000 1.000000 164.26667 REMARK 290 SMTRY1 16 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 16 0.866025 0.500000 0.000000 87.52630 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 164.26667 REMARK 290 SMTRY1 17 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 17 0.000000 -1.000000 0.000000 87.52630 REMARK 290 SMTRY3 17 0.000000 0.000000 -1.000000 164.26667 REMARK 290 SMTRY1 18 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 18 -0.866025 0.500000 0.000000 87.52630 REMARK 290 SMTRY3 18 0.000000 0.000000 -1.000000 164.26667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAINA FORMS A BIOLOGICAL DIMER WITH A SYMMETRIC REMARK 300 MOLECULE BY INTERACTION OF 4 HELICES. THE DODECAMETRIC ASSEMBLY REMARK 300 SHOWN IN THE ASSEMBLY INFORMATION RESULTS FROM THE ASSOCIATION REMARK 300 OF 3 BIOLOGICAL DIMERS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 42860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -155.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 75.80000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 -43.76315 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -82.13333 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 43490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 129720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -553.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -75.80000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 -43.76315 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -82.13333 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 75.80000 REMARK 350 BIOMT2 3 0.866025 0.500000 0.000000 -43.76315 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 -82.13333 REMARK 350 BIOMT1 4 -0.500000 -0.866025 0.000000 -75.80000 REMARK 350 BIOMT2 4 0.866025 -0.500000 0.000000 -131.28945 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 5 -0.500000 0.866025 0.000000 75.80000 REMARK 350 BIOMT2 5 -0.866025 -0.500000 0.000000 -131.28945 REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 6 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 6 0.000000 -1.000000 0.000000 -175.05260 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 -82.13333 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -71.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2086 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1 REMARK 465 GLY A 2 REMARK 465 ARG A 3 REMARK 465 GLU A 4 REMARK 465 LYS A 568 REMARK 465 ASN A 569 REMARK 465 GLN A 570 REMARK 465 PHE A 571 REMARK 465 ASP A 572 REMARK 465 HIS A 573 REMARK 465 TYR A 574 REMARK 465 SER A 575 REMARK 465 LYS A 576 REMARK 465 GLN A 577 REMARK 465 ASP A 578 REMARK 465 ARG A 579 REMARK 465 CYS A 580 REMARK 465 SER A 581 REMARK 465 ASP A 582 REMARK 465 LEU A 583 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 548 CD REMARK 480 GLU A 550 CD REMARK 480 ARG A 551 CZ REMARK 480 GLN A 552 CD REMARK 480 TRP A 553 CD1 CD2 CH2 REMARK 480 GLU A 556 CB CD REMARK 480 HIS A 558 CG REMARK 480 ARG A 559 NE REMARK 480 TRP A 560 CD1 REMARK 480 SER A 562 OG REMARK 480 TYR A 563 CD1 REMARK 480 VAL A 565 CB REMARK 480 HIS A 566 ND1 REMARK 480 TRP A 567 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU A 491 O HOH A 2106 2.17 REMARK 500 O SER A 512 O HOH A 2103 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 6 -64.42 61.89 REMARK 500 GLU A 7 67.23 -156.23 REMARK 500 PHE A 47 -11.74 73.79 REMARK 500 PRO A 88 119.32 -38.91 REMARK 500 ALA A 167 85.77 -154.55 REMARK 500 PRO A 194 7.86 -66.46 REMARK 500 SER A 203 -129.23 64.05 REMARK 500 PRO A 259 -146.71 -84.95 REMARK 500 THR A 262 78.50 -166.98 REMARK 500 PRO A 290 -70.65 -58.35 REMARK 500 ASP A 306 -91.72 -79.76 REMARK 500 SER A 352 52.17 37.38 REMARK 500 VAL A 407 -67.06 -128.04 REMARK 500 GLU A 431 55.30 -117.70 REMARK 500 HIS A 447 107.48 -27.67 REMARK 500 ASN A 464 54.82 -91.24 REMARK 500 GLU A 491 170.07 62.59 REMARK 500 ARG A 493 -156.20 -113.31 REMARK 500 PRO A 495 -144.47 -71.94 REMARK 500 ASN B 20 -153.37 -72.29 REMARK 500 ASP B 45 -156.30 -163.37 REMARK 500 THR B 54 -83.13 -128.61 REMARK 500 ASP B 57 118.33 72.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B41 RELATED DB: PDB REMARK 900 HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II, REMARK 900 GLYCOSYLATED PROTEIN REMARK 900 RELATED ID: 1F8U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MUTANT E202Q OF HUMANACETYLCHOLINESTERASE REMARK 900 COMPLEXED WITH GREEN MAMBA VENOMPEPTIDE FASCICULIN-II REMARK 900 RELATED ID: 1FSC RELATED DB: PDB REMARK 900 FASCICULIN 2 (SYNCHROTRON X-RAY DIFFRACTION) REMARK 900 RELATED ID: 1FSS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II REMARK 900 RELATED ID: 1KU6 RELATED DB: PDB REMARK 900 FASCICULIN 2-MOUSE ACETYLCHOLINESTERASE COMPLEX REMARK 900 RELATED ID: 1MAH RELATED DB: PDB REMARK 900 FASCICULIN2 - MOUSE ACETYLCHOLINESTERASE COMPLEX REMARK 900 RELATED ID: 1PUV RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,7-HEPTYLENE-BIS-N ,N'-SYN-2- REMARK 900 PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1PUW RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,3-PROPYLENE-BIS-N ,N'-SYN-4- REMARK 900 PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1VZJ RELATED DB: PDB REMARK 900 STRUCTURE OF THE TETRAMERIZATION DOMAIN OF ACETYLCHOLINESTERASE: REMARK 900 FOUR-FOLD INTERACTION OF A WWW MOTIF WITH A LEFT-HANDED POLYPROLINE REMARK 900 HELIX REMARK 900 RELATED ID: 2CLJ RELATED DB: PDB REMARK 900 HOMOLOGY-BUILT MODEL OF HUMAN ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 2X8B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE INHIBITED BY AGED REMARK 900 TABUN AND COMPLEXED WITH FASCICULIN-II REMARK 900 RELATED ID: 4BDS RELATED DB: PDB REMARK 900 HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TACRINE DBREF 4BDT A 1 583 UNP P22303 ACES_HUMAN 32 614 DBREF 4BDT B 1 61 UNP P0C1Z0 TXFA2_DENAN 1 61 SEQRES 1 A 583 GLU GLY ARG GLU ASP ALA GLU LEU LEU VAL THR VAL ARG SEQRES 2 A 583 GLY GLY ARG LEU ARG GLY ILE ARG LEU LYS THR PRO GLY SEQRES 3 A 583 GLY PRO VAL SER ALA PHE LEU GLY ILE PRO PHE ALA GLU SEQRES 4 A 583 PRO PRO MET GLY PRO ARG ARG PHE LEU PRO PRO GLU PRO SEQRES 5 A 583 LYS GLN PRO TRP SER GLY VAL VAL ASP ALA THR THR PHE SEQRES 6 A 583 GLN SER VAL CYS TYR GLN TYR VAL ASP THR LEU TYR PRO SEQRES 7 A 583 GLY PHE GLU GLY THR GLU MET TRP ASN PRO ASN ARG GLU SEQRES 8 A 583 LEU SER GLU ASP CYS LEU TYR LEU ASN VAL TRP THR PRO SEQRES 9 A 583 TYR PRO ARG PRO THR SER PRO THR PRO VAL LEU VAL TRP SEQRES 10 A 583 ILE TYR GLY GLY GLY PHE TYR SER GLY ALA SER SER LEU SEQRES 11 A 583 ASP VAL TYR ASP GLY ARG PHE LEU VAL GLN ALA GLU ARG SEQRES 12 A 583 THR VAL LEU VAL SER MET ASN TYR ARG VAL GLY ALA PHE SEQRES 13 A 583 GLY PHE LEU ALA LEU PRO GLY SER ARG GLU ALA PRO GLY SEQRES 14 A 583 ASN VAL GLY LEU LEU ASP GLN ARG LEU ALA LEU GLN TRP SEQRES 15 A 583 VAL GLN GLU ASN VAL ALA ALA PHE GLY GLY ASP PRO THR SEQRES 16 A 583 SER VAL THR LEU PHE GLY GLU SER ALA GLY ALA ALA SER SEQRES 17 A 583 VAL GLY MET HIS LEU LEU SER PRO PRO SER ARG GLY LEU SEQRES 18 A 583 PHE HIS ARG ALA VAL LEU GLN SER GLY ALA PRO ASN GLY SEQRES 19 A 583 PRO TRP ALA THR VAL GLY MET GLY GLU ALA ARG ARG ARG SEQRES 20 A 583 ALA THR GLN LEU ALA HIS LEU VAL GLY CYS PRO PRO GLY SEQRES 21 A 583 GLY THR GLY GLY ASN ASP THR GLU LEU VAL ALA CYS LEU SEQRES 22 A 583 ARG THR ARG PRO ALA GLN VAL LEU VAL ASN HIS GLU TRP SEQRES 23 A 583 HIS VAL LEU PRO GLN GLU SER VAL PHE ARG PHE SER PHE SEQRES 24 A 583 VAL PRO VAL VAL ASP GLY ASP PHE LEU SER ASP THR PRO SEQRES 25 A 583 GLU ALA LEU ILE ASN ALA GLY ASP PHE HIS GLY LEU GLN SEQRES 26 A 583 VAL LEU VAL GLY VAL VAL LYS ASP GLU GLY SER TYR PHE SEQRES 27 A 583 LEU VAL TYR GLY ALA PRO GLY PHE SER LYS ASP ASN GLU SEQRES 28 A 583 SER LEU ILE SER ARG ALA GLU PHE LEU ALA GLY VAL ARG SEQRES 29 A 583 VAL GLY VAL PRO GLN VAL SER ASP LEU ALA ALA GLU ALA SEQRES 30 A 583 VAL VAL LEU HIS TYR THR ASP TRP LEU HIS PRO GLU ASP SEQRES 31 A 583 PRO ALA ARG LEU ARG GLU ALA LEU SER ASP VAL VAL GLY SEQRES 32 A 583 ASP HIS ASN VAL VAL CYS PRO VAL ALA GLN LEU ALA GLY SEQRES 33 A 583 ARG LEU ALA ALA GLN GLY ALA ARG VAL TYR ALA TYR VAL SEQRES 34 A 583 PHE GLU HIS ARG ALA SER THR LEU SER TRP PRO LEU TRP SEQRES 35 A 583 MET GLY VAL PRO HIS GLY TYR GLU ILE GLU PHE ILE PHE SEQRES 36 A 583 GLY ILE PRO LEU ASP PRO SER ARG ASN TYR THR ALA GLU SEQRES 37 A 583 GLU LYS ILE PHE ALA GLN ARG LEU MET ARG TYR TRP ALA SEQRES 38 A 583 ASN PHE ALA ARG THR GLY ASP PRO ASN GLU PRO ARG ASP SEQRES 39 A 583 PRO LYS ALA PRO GLN TRP PRO PRO TYR THR ALA GLY ALA SEQRES 40 A 583 GLN GLN TYR VAL SER LEU ASP LEU ARG PRO LEU GLU VAL SEQRES 41 A 583 ARG ARG GLY LEU ARG ALA GLN ALA CYS ALA PHE TRP ASN SEQRES 42 A 583 ARG PHE LEU PRO LYS LEU LEU SER ALA THR ASP THR LEU SEQRES 43 A 583 ASP GLU ALA GLU ARG GLN TRP LYS ALA GLU PHE HIS ARG SEQRES 44 A 583 TRP SER SER TYR MET VAL HIS TRP LYS ASN GLN PHE ASP SEQRES 45 A 583 HIS TYR SER LYS GLN ASP ARG CYS SER ASP LEU SEQRES 1 B 61 THR MET CYS TYR SER HIS THR THR THR SER ARG ALA ILE SEQRES 2 B 61 LEU THR ASN CYS GLY GLU ASN SER CYS TYR ARG LYS SER SEQRES 3 B 61 ARG ARG HIS PRO PRO LYS MET VAL LEU GLY ARG GLY CYS SEQRES 4 B 61 GLY CYS PRO PRO GLY ASP ASP ASN LEU GLU VAL LYS CYS SEQRES 5 B 61 CYS THR SER PRO ASP LYS CYS ASN TYR MODRES 4BDT ASN A 350 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET FUL C 3 10 HET HUW A 701 22 HET CL A 802 1 HET CL A 803 1 HET CL A 804 1 HET CL A 805 1 HET CL A 806 1 HET CL A 807 1 HET CL A 808 1 HET CL A 809 1 HET CL A 810 1 HET CL A 811 1 HET SO4 A 812 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM HUW HUPRINE W HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 3 FUL C6 H12 O5 FORMUL 4 HUW C18 H19 CL N2 O FORMUL 5 CL 10(CL 1-) FORMUL 15 SO4 O4 S 2- FORMUL 16 HOH *119(H2 O) HELIX 1 1 MET A 42 ARG A 46 5 5 HELIX 2 2 LEU A 130 ASP A 134 5 5 HELIX 3 3 GLY A 135 ARG A 143 1 9 HELIX 4 4 GLY A 154 LEU A 159 1 6 HELIX 5 5 ASN A 170 VAL A 187 1 18 HELIX 6 6 ALA A 188 PHE A 190 5 3 HELIX 7 7 SER A 203 LEU A 213 1 11 HELIX 8 8 SER A 215 GLY A 220 1 6 HELIX 9 9 GLY A 240 VAL A 255 1 16 HELIX 10 10 ASP A 266 ARG A 276 1 11 HELIX 11 11 PRO A 277 HIS A 284 1 8 HELIX 12 12 GLU A 285 LEU A 289 5 5 HELIX 13 13 THR A 311 GLY A 319 1 9 HELIX 14 14 GLY A 335 GLY A 342 5 8 HELIX 15 15 SER A 355 VAL A 367 1 13 HELIX 16 16 SER A 371 THR A 383 1 13 HELIX 17 17 ASP A 390 VAL A 407 1 18 HELIX 18 18 VAL A 407 ALA A 420 1 14 HELIX 19 19 PRO A 440 GLY A 444 5 5 HELIX 20 20 GLU A 450 PHE A 455 1 6 HELIX 21 21 GLY A 456 ASP A 460 5 5 HELIX 22 22 THR A 466 GLY A 487 1 22 HELIX 23 23 ARG A 525 ARG A 534 1 10 HELIX 24 24 ARG A 534 GLU A 548 1 15 HELIX 25 25 GLU A 550 TRP A 567 1 18 SHEET 1 AA 3 LEU A 9 VAL A 12 0 SHEET 2 AA 3 GLY A 15 ARG A 18 -1 O GLY A 15 N VAL A 12 SHEET 3 AA 3 VAL A 59 ASP A 61 1 O VAL A 60 N ARG A 18 SHEET 1 AB11 ILE A 20 LYS A 23 0 SHEET 2 AB11 PRO A 28 PRO A 36 -1 O VAL A 29 N LEU A 22 SHEET 3 AB11 TYR A 98 PRO A 104 -1 O LEU A 99 N ILE A 35 SHEET 4 AB11 VAL A 145 MET A 149 -1 O LEU A 146 N TRP A 102 SHEET 5 AB11 THR A 112 ILE A 118 1 O PRO A 113 N VAL A 145 SHEET 6 AB11 GLY A 192 GLU A 202 1 N ASP A 193 O THR A 112 SHEET 7 AB11 ARG A 224 GLN A 228 1 O ARG A 224 N LEU A 199 SHEET 8 AB11 GLN A 325 VAL A 331 1 O GLN A 325 N ALA A 225 SHEET 9 AB11 ARG A 424 PHE A 430 1 O ARG A 424 N VAL A 326 SHEET 10 AB11 GLN A 509 LEU A 513 1 O VAL A 511 N VAL A 429 SHEET 11 AB11 GLU A 519 ARG A 522 -1 O GLU A 519 N SER A 512 SHEET 1 AC 2 VAL A 68 CYS A 69 0 SHEET 2 AC 2 LEU A 92 SER A 93 1 N SER A 93 O VAL A 68 SHEET 1 BA 2 MET B 2 SER B 5 0 SHEET 2 BA 2 ILE B 13 ASN B 16 -1 O ILE B 13 N SER B 5 SHEET 1 BB 3 VAL B 34 CYS B 39 0 SHEET 2 BB 3 CYS B 22 ARG B 27 -1 O TYR B 23 N GLY B 38 SHEET 3 BB 3 LEU B 48 CYS B 53 -1 O GLU B 49 N SER B 26 SSBOND 1 CYS A 69 CYS A 96 1555 1555 2.05 SSBOND 2 CYS A 257 CYS A 272 1555 1555 2.04 SSBOND 3 CYS A 409 CYS A 529 1555 1555 2.06 SSBOND 4 CYS B 3 CYS B 22 1555 1555 2.03 SSBOND 5 CYS B 17 CYS B 39 1555 1555 2.04 SSBOND 6 CYS B 41 CYS B 52 1555 1555 2.04 SSBOND 7 CYS B 53 CYS B 59 1555 1555 2.04 LINK ND2 ASN A 350 C1 NAG C 1 1555 1555 1.46 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.47 LINK O6 NAG C 1 C1 FUL C 3 1555 1555 1.45 CISPEP 1 TYR A 105 PRO A 106 0 0.68 CISPEP 2 GLY A 264 ASN A 265 0 10.11 CISPEP 3 ASN A 265 ASP A 266 0 0.06 CISPEP 4 PRO B 30 PRO B 31 0 -3.81 CRYST1 151.600 151.600 246.400 90.00 90.00 120.00 H 3 2 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006596 0.003808 0.000000 0.00000 SCALE2 0.000000 0.007617 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004058 0.00000